RxDoctor Payments Data

Todd Dreitzler, MD

Family Medicine · Tempe, AZNPI 1063641686

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 11 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Lumenis BE Inc accounts for 70.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $494 and has fallen 94.0% since, to $30 in 2025.

$647in general payments, 2019–2025

Across 11 payments — averaging $58.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lumenis BE Inc$459
  • Johnson & Johnson$58
  • Fidia Pharma USA Inc.$43
  • Bioventus LLC$43
  • Sanofi$30
  • Hologic Sales And Service, LLC$15
$4,678,359in research payments, 2019–2025

Across 1,180 payments — averaging $3964.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$1.9M
  • Vertex$946K
  • Eli Lilly$696K
  • Sanofi US Services Inc.$507K
  • Boehringer Ingelheim International GmbH$252K
  • Cleerly, Inc.$108K
  • plus $235K from 6 others

What the payments were for

  • Food & beverage$647100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$647 in reported general payments places this provider in the 65th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$37,457
Medicare patients
72
Services billed
881

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Tempe

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →